Sol-Gel Technologies Ltd. (SLGL)
81.72
+4.33
(+5.60%)
USD |
NASDAQ |
Aug 25, 16:00
81.31
-0.41
(-0.50%)
After-Hours: 19:59
Sol-Gel Technologies Enterprise Value : 220.39M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 220.39M |
| August 24, 2026 | 206.22M |
| August 21, 2026 | 207.33M |
| August 20, 2026 | 209.83M |
| August 19, 2026 | 210.14M |
| August 18, 2026 | 212.57M |
| August 17, 2026 | 224.62M |
| August 14, 2026 | 230.12M |
| August 13, 2026 | 227.99M |
| August 12, 2026 | 186.93M |
| August 11, 2026 | 207.95M |
| August 10, 2026 | 230.28M |
| August 07, 2026 | 240.95M |
| August 06, 2026 | 237.35M |
| August 05, 2026 | 240.95M |
| August 04, 2026 | 229.48M |
| August 03, 2026 | 221.28M |
| July 31, 2026 | 222.13M |
| July 30, 2026 | 231.75M |
| July 29, 2026 | 223.09M |
| July 28, 2026 | 224.81M |
| July 27, 2026 | 214.20M |
| July 24, 2026 | 221.18M |
| July 23, 2026 | 216.56M |
| July 22, 2026 | 228.84M |
| Date | Value |
|---|---|
| July 21, 2026 | 246.65M |
| July 20, 2026 | 215.09M |
| July 17, 2026 | 225.24M |
| July 16, 2026 | 208.47M |
| July 15, 2026 | 205.64M |
| July 14, 2026 | 199.67M |
| July 13, 2026 | 194.82M |
| July 10, 2026 | 194.95M |
| July 09, 2026 | 202.84M |
| July 08, 2026 | 197.61M |
| July 07, 2026 | 209.65M |
| July 06, 2026 | 195.51M |
| July 02, 2026 | 195.15M |
| July 01, 2026 | 188.54M |
| June 30, 2026 | 195.58M |
| June 29, 2026 | 191.28M |
| June 26, 2026 | 188.31M |
| June 25, 2026 | 185.59M |
| June 24, 2026 | 187.98M |
| June 23, 2026 | 180.98M |
| June 22, 2026 | 189.29M |
| June 18, 2026 | 191.44M |
| June 17, 2026 | 178.04M |
| June 16, 2026 | 186.25M |
| June 15, 2026 | 189.35M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 57.61B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 141.64M |
| Purple Biotech Ltd. | -3.359M |
| PolyPid Ltd. | 98.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.681M |
| Revenue (Quarterly) | 0.591M |
| Total Expenses (Quarterly) | 4.272M |
| EPS Diluted (Quarterly) | -1.126 |
| Profit Margin (Quarterly) | -622.8% |
| Earnings Yield | -6.91% |
| Normalized Earnings Yield | -6.907 |